Table 1.

Clinical background.

		Total	Group I <1 year	Group II 1 < years < 2	Group III >4 years
SVM model training patients
Cases		69	16	22	31
ROI	HCC	1369	219	558	592
	non-HCC	738	136	273	329
	Total	2107	355	831	921
Nuclei	HCC	979,086	130,178	413,665	435,243
	Normal	328,463	57,437	120,702	150,324
	Total	1,307,549	187,615	534,367	585,567
Gender	M	48	11	16	21
	F	21	5	6	10
Age	Average	65.4	65.8	67.0	64.0
	MAX	80	75	80	80
	MIN	40	42	54	40
Virus	HBV	19	5	6	8
	HCV	36	8	13	15
	NBNC	14	3	3	8
Background	LC	34	8	11	15
	CH	32	8	11	13
	Normal	3	0	0	3
Size (mm)	Average	27.8	28.3	26.5	28.4
	MAX	48.0	48.0	43.0	47.0
	MIN	9.0	20.0	9.0	10.0
Nodule	Average	1.3	1.7	1.1	1.2
	MAX	3	3	2	3
	MIN	1	1	1	1
SVM model test patients
Cases		89	23	28	38
ROI	HCC	1346	434	324	588
	non-HCC	680	189	168	323
	Total	2026	623	492	911
Nuclei	HCC	886,900	317,855	185,672	383,373
	Normal	251,376	66,243	59,148	125,985
	Total	1,138,276	384,098	244,820	509,358
Gender	M	67	17	23	27
	F	22	6	5	11
Age	Average	67.8	68.2	71.3	65.1
	MAX	83	79	82	83
	MIN	28	47	46	28
Virus	HBV	12	2	0	10
	HCV	53	16	17	20
	NBNC	24	5	11	8
Background	LC	53	16	14	23
	CH	32	7	12	13
	NON	4	0	2	2
Size (mm)	Average	26.3	38.5	27.7	24.2
	MAX	45.0	45.0	45.0	45.0
	MIN	10.0	15.0	14.0	10.0
Nodule	Average	1.3	1.7	1.4	1.1
	MAX	3	3	3	2
	MIN	1	1	1	1

HCC HCC area, non-HCC surrounding non-HCC area, ROI used ROI number, Nuclei calculated number of nuclei, NBNC neither HBV nor HCV infection.